News

Rolling Out5h
6 important oral health issues people with HIV should know
People living with HIV face unique oral health challenges that require special attention and care. The virus's impact on the ...
BlackDoctor.org6h
Tongue and Mouth Signs of HIV
You can notice signs of HIV on the tongue during the early and late stages of the infection with the virus. An acute HIV ...
Health on MSN1d
How HIV Can Affect Your Tongue and Oral Health
Medically reviewed by Renita White, MD Mouth and tongue lesions are often one of the first symptoms of human immunodeficiency ...
Morningstar2mon
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan - Morningstar
Oral warts are a frequent and painful complication in HIV-positive patients. According to UNAIDS, approximately 39.9 million people globally live with HIV in 2023, ...
Nasdaq2mon
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan - Nasdaq
SAN DIEGO, CALIFORNIA/ ACCESS Newswire/ April 14, 2025/ Ainos, Inc., pioneer of low-dose oral interferon therapeutics, today announced significant progress in advancing its oral interferon drug ...
Yahoo Finance2mon
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan - Yahoo Finance
Dual Trials Accelerate VELDONA® Toward Rare Disease Market Entry Bridging Strategy Aims to Fast-Track U.S. Regulatory Approvals SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos ...
PharmiWeb2mon
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts
"HIV-related oral warts and primary Sjögren's Syndrome both lack effective standard treatments and impose meaningful burdens on quality of life. As an oral therapy, VELDONA® provides a convenient, non ...
The Globe and Mail2mon
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
SAN DIEGO, CALIFORNIA / ACCESS Newswire / April 14, 2025 / Ainos, Inc. (Nasdaq:AIMD, AIMDW) ("Ainos" or the "Company"), pioneer of low-dose oral interferon therapeutics, today announced ...